Ocean Biomedical Inc 8AW0
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €1.31
- Day Range
- €1.35–1.36
- 52-Week Range
- €0.48–7.05
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €47.12 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 9
- Website
- https://www.oceanbiomedical.com
Comparables
Valuation
|
Metric
|
8AW0
|
KOD
|
EQRX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 0.61 | 0.97 |
Price/Sales | — | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
8AW0
|
KOD
|
EQRX
|
|---|---|---|---|
Quick Ratio | 0.00 | 9.89 | 18.43 |
Current Ratio | 0.03 | 10.12 | 18.78 |
Interest Coverage | −72.65 | −27,690.00 | — |
Quick Ratio
8AW0
KOD
EQRX
Profitability
|
Metric
|
8AW0
|
KOD
|
EQRX
|
|---|---|---|---|
Return on Assets (Normalized) | −115.82% | −28.19% | −15.72% |
Return on Equity (Normalized) | −822.89% | −49.26% | −16.71% |
Return on Invested Capital (Normalized) | −333.05% | −43.02% | −21.31% |
Return on Assets
8AW0
KOD
EQRX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| Frypzwpc | Krdyph | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Wzmsmrt | Mblhfyr | $114.2 Bil | |||
| Moderna Inc
MRNA
| Rztxllz | Jqd | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Vcgwrxw | Dgyn | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Zqrmhlz | Fhmg | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Jptvfqnzg | Wbqnvz | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Rbqgysqh | Xpdmrpc | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Zlhxtjrh | Ctrs | $12.8 Bil | |||
| Incyte Corp
INCY
| Yvjtnxtr | Ythxt | $12.2 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Zxbjxwljp | Ypngkx | $12.2 Bil |